Koukoulis Georgios D, Bouliaris Konstantinos, Perivoliotis Konstantinos, Tepetes Konstantinos
School of Medicine, University of Thessaly, Larisa, GRC.
Cureus. 2021 Nov 17;13(11):e19669. doi: 10.7759/cureus.19669. eCollection 2021 Nov.
This randomized controlled study aims to investigate the prophylactic effect of tamsulosin on the development of postoperative urinary retention (POUR) in men undergoing elective open inguinal hernia (IH) repair under spinal anesthesia. The study also focused on potentially predisposing factors for POUR.
100 eligible patients were randomized into two groups. Patients in the experimental group were given two doses of tamsulosin 0.4 mg orally 24 hours and 6 hours before surgery. In the control group, two doses of placebo were administered, in the same manner as the study group. The following parameters were also recorded: the International Prostate Symptom Score (IPSS) questionnaire scores, the presence of scrotal hernia, operation duration, perioperative administration of IV opioids and/or atropine, postoperative pain, and preoperative anxiety.
Overall, the incidence of POUR was 37% (37/100) with no difference between the two groups. Among patients receiving tamsulosin, 39.2% (20/51) developed POUR, compared to 34.7% (17/49) in the control group. Preoperative patients' high anxiety visual analog scale (VAS) score (>51mm) (P=0.007) and the intraoperative use of atropine (P=0.02) were detected as risk factors for POUR.
This interim analysis of our prospective randomized trial showed no benefit from the prophylactic use of tamsulosin in preventing POUR after IH repair under spinal anesthesia. This type of anesthesia was also correlated with an overall high incidence of POUR. Preoperative anxiety and administration of atropine were identified as statistically significant factors for POUR. In patients with preoperative high anxiety, VAS score a different type of anesthesia may be used.
本随机对照研究旨在探讨坦索罗辛对接受脊髓麻醉下择期开放性腹股沟疝(IH)修补术男性患者术后尿潴留(POUR)发生的预防作用。该研究还关注了POUR的潜在诱发因素。
100例符合条件的患者被随机分为两组。实验组患者在手术前24小时和6小时口服两剂0.4毫克坦索罗辛。在对照组中,以与研究组相同的方式给予两剂安慰剂。还记录了以下参数:国际前列腺症状评分(IPSS)问卷得分、阴囊疝的存在情况、手术持续时间、围手术期静脉注射阿片类药物和/或阿托品的使用情况、术后疼痛以及术前焦虑情况。
总体而言,POUR的发生率为37%(37/100),两组之间无差异。在接受坦索罗辛治疗的患者中,39.2%(20/51)发生了POUR,而对照组为34.7%(17/49)。术前患者的高焦虑视觉模拟量表(VAS)评分(>51mm)(P = 0.007)和术中使用阿托品(P = 0.02)被检测为POUR的危险因素。
我们前瞻性随机试验的这项中期分析表明,在脊髓麻醉下进行IH修补术后预防性使用坦索罗辛对预防POUR没有益处。这种麻醉方式也与POUR的总体高发生率相关。术前焦虑和阿托品的使用被确定为POUR的统计学显著因素。对于术前焦虑程度高、VAS评分高的患者,可使用不同类型的麻醉。